Oscar Health, Inc. current report, 02 August 2023

Oscar Health, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Oscar Health, Inc. on August 2, 2023. The filing primarily serves to announce the Company's financial results for the quarter ended June 30, 2023, and to disclose a significant change in executive leadership effective August 14, 2023.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.

Material Changes and Executive Transition

  • Leadership Change: R. Scott Blackley will assume the role of Chief Financial Officer (CFO) effective August 14, 2023.
  • Outgoing CFO: Siddhartha Sankaran will serve as CFO through August 14, 2023, and will continue to serve on the Company's Board of Directors.
  • Role Adjustment: Mr. Blackley, currently the Chief Transformation Officer and former CFO (March 2021 to November 2022), will serve as the principal financial officer and will no longer serve as the principal operating officer.
  • Compensation: Other than the title change, the material terms of Mr. Blackley's employment remain unchanged.

Guidance, Outlook, and Risks

The filing text does not contain specific guidance, outlook, management commentary, or risk factors. Investors are directed to the press release (Exhibit 99.1) for the Company's financial results and related commentary. The filing includes a standard disclaimer that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act.

Key Facts for Investor Verification

  • Review Exhibit 99.1 (Press Release dated August 8, 2023) for actual Q2 2023 financial performance data.
  • Confirm the effective date of the CFO transition (August 14, 2023) and the continued board membership of Mr. Sankaran.
  • Verify that Mr. Blackley's compensation terms remain unchanged despite the shift from principal operating officer to principal financial officer.